OTC labeling rule would crowd out important consumer information, claims -- CTFA.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABEL PROPOSAL INHIBITS "IMPORTANT CONSUMER INFORMATION," CTFA said at FDA's Nonprescription Drugs Advisory Committee July 14 in Bethesda, MD. Commenting on the revised OTC labeling format proposed by FDA Feb. 27, Cosmetic, Toiletry & Fragrance Association Assistant General Counsel Stephen Gettings maintained that "other important consumer information...not required by any government agency," but included on cosmetics packaging, is not accounted for under FDA's proposed labeling reg. Claims such as non-comedogenic, PABA free and fragrance free would be crowded out of labeling due the amount of information required within a rigid template under the agency's proposal, Gettings maintained.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning